By Canadian Press

Canada probing whether delaying second COVID-19 vaccine doses could help more people

Jan 5, 2021 | 11:26 AM

OTTAWA — Canada’s chief public health officer says she has asked the national vaccine advisory panel to investigate if there is merit to delaying second doses of COVID-19 vaccines in a bid to get more people vaccinated faster with first doses.

The request comes after the United Kingdom said it will delay the second doses of vaccines from Pfizer-BioNTech and AstraZeneca, up to 12 weeks.

Pfizer-BioNTech’s product is supposed to be given in two doses 21 days apart, and AstraZeneca’s in two doses 28 days apart.

Health Canada has not yet authorized AstraZeneca’s vaccine candidate but approved Pfizer-BioNTech’s on Dec. 9 and another from Massachusetts-based biotech firm Moderna on Dec. 23.

A written statement from Pfizer says ultimately alternative dosing decisions are up to local health authorities, but that the company has no evidence protection after the first dose remains in place after 21 days.

IN THE COMMUNITY

Medicine Hat's Adopt-A-Rink program still seeking volunteers

11h ago

HOLIDAYS

Medicine Hat Kiwanis hosting Christmas dinner

Dec 06, 2024

IN THE COMMUNITY

CHAT News producer makes 'emotional' return to Medicine Hat's old arena

Dec 06, 2024

Tam says the National Advisory Committee on Immunization is being asked to provide analysis on what is known about the dosing regimens and what should be considered in deciding whether or not to delay the second doses.

This report by The Canadian Press was first published Jan. 5, 2021.

Mia Rabson, The Canadian Press